James Scanlon

2.0k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

James Scanlon is a scholar working on Oncology, Epidemiology and Physiology. According to data from OpenAlex, James Scanlon has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Epidemiology and 3 papers in Physiology. Recurrent topics in James Scanlon's work include Full-Duplex Wireless Communications (3 papers), Polyomavirus and related diseases (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). James Scanlon is often cited by papers focused on Full-Duplex Wireless Communications (3 papers), Polyomavirus and related diseases (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). James Scanlon collaborates with scholars based in United States, Switzerland and Netherlands. James Scanlon's co-authors include Alfred Sandrock, Carmen Bozic, Meena Subramanyam, Gary Bloomgren, Sandra Richman, Tatiana Plavina, Sophia Lee, Christophe Hotermans, Susan Goelz and Alexander Turchin and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Annals of Neurology.

In The Last Decade

James Scanlon

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

2012 878 citations Gary Bloomgren, Sandra Richman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Scanlon United States	9	594	573	350	265	231	14	1.4k
Gary Bloomgren United States	12	1.1k 1.9×	930 1.6×	425 1.2×	170 0.6×	407 1.8×	17	2.1k
Raquel Planas Spain	22	257 0.4×	204 0.4×	198 0.6×	464 1.8×	82 0.4×	34	1.2k
Carmen Bozic United States	13	934 1.6×	819 1.4×	29 0.1×	179 0.7×	423 1.8×	37	2.1k
Ilijas Jelčić Switzerland	20	419 0.7×	473 0.8×	29 0.1×	57 0.2×	142 0.6×	55	1.5k
Esperanza Jordá Spain	19	590 1.0×	253 0.4×	14 0.0×	162 0.6×	110 0.5×	127	1.5k
JC Lee United States	14	242 0.4×	201 0.4×	35 0.1×	43 0.2×	51 0.2×	36	846
Annalisa Rossi Italy	21	305 0.5×	128 0.2×	167 0.5×	61 0.2×	13 0.1×	43	1.5k
Rafael Arroyo Spain	26	333 0.6×	762 1.3×	13 0.0×	104 0.4×	46 0.2×	76	1.7k
Gaye Hafez United States	19	480 0.8×	139 0.2×	38 0.1×	29 0.1×	86 0.4×	59	1.1k
Alexandros Tselis United States	21	319 0.5×	729 1.3×	19 0.1×	19 0.1×	82 0.4×	40	1.3k

Countries citing papers authored by James Scanlon

Since Specialization

Citations

This map shows the geographic impact of James Scanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Scanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Scanlon more than expected).

Fields of papers citing papers by James Scanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Scanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Scanlon. The network helps show where James Scanlon may publish in the future.

Co-authorship network of co-authors of James Scanlon

This figure shows the co-authorship network connecting the top 25 collaborators of James Scanlon. A scholar is included among the top collaborators of James Scanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Scanlon. James Scanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

McAllister, Peter J., Ira Turner, Uwe Reuter, et al.. (2021). Timing and durability of response to erenumab in patients with episodic migraine. Headache The Journal of Head and Face Pain. 61(10). 1553–1561. 10 indexed citations

2.

Tepper, Stewart J., Sylvia Lucas, Messoud Ashina, et al.. (2021). Timing and durability of response to erenumab in patients with chronic migraine. Headache The Journal of Head and Face Pain. 61(8). 1255–1263. 8 indexed citations

3.

Bloomgren, Gary, Sandra Richman, Christophe Hotermans, et al.. (2012). Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. New England Journal of Medicine. 366(20). 1870–1880. 878 indexed citations breakdown →

4.

Balcer, Laura J., Steven Galetta, Chris H. Polman, et al.. (2012). Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS. Journal of the Neurological Sciences. 318(1-2). 119–124. 47 indexed citations

5.

Bloomgren, Gary, Sandra Richman, Christophe Hotermans, et al.. (2012). Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Survey of Anesthesiology. 56(6). 329–330. 8 indexed citations

6.

Bozic, Carmen, Sandra Richman, Tatiana Plavina, et al.. (2011). Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1. Annals of Neurology. 70(5). 742–750. 102 indexed citations

7.

Melillo, Stephanie, et al.. (2010). Rivaroxaban for Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery. Annals of Pharmacotherapy. 44(6). 1061–1071. 11 indexed citations

8.

Turchin, Alexander, Michael E. Matheny, Maria Shubina, et al.. (2009). Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward. Diabetes Care. 32(12). e152–e152. 22 indexed citations

9.

Scanlon, James, et al.. (2009). Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis. Annals of Pharmacotherapy. 43(9). 1456–1465. 13 indexed citations

10.

Turchin, Alexander, Michael E. Matheny, Maria Shubina, et al.. (2009). Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward. Diabetes Care. 32(7). 1153–1157. 334 indexed citations

11.

Scanlon, James, et al.. (1978). The Impact of Rehabilitation Services in County Jails. 2(4). 383–388. 2 indexed citations

12.

Scanlon, James. (1975). Self-Reported Health Behavior and Attitudes of Youths 12-17 Years: United States. PsycEXTRA Dataset. 1–88. 3 indexed citations

13.

Scanlon, James. (1975). Self-Reported Health Behavior and Attitudes of Youths 12-17 Years, United States. Data from the National Health Survey, Series 11, Number 147.. 1 indexed citations

14.

Kelly, James E. & James Scanlon. (1974). Decayed,Missing,And filled teeth among children, United States.. PubMed. 1–53. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact